연구동향 분석

A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer

유창훈 김성배 안진희 김정은 정경해 공경엽 손병호 안세현 안승도 김학희 신희정 김우건 2015년

논문상세정보
인용/피인용
' A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • anthracyclines
  • breast neoplasm
  • capecitabine
  • neoadjuvant therapy
  • vinorelbine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,350 0

0.0%

' A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer' 의 참고문헌

  • Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer : National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    Bear HD J Clin Oncol 24 : 2019 ~ 2027 [2006]
  • Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer : National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    Bear HD J Clin Oncol 24 2019-2027 [2006]
  • Response-guided neoadjuvant chemotherapy for breast cancer
    von Minckwitz G J Clin Oncol 31 : 3623 ~ 3630 [2013]
  • Response-guided neoadjuvant chemotherapy for breast cancer
    von Minckwitz G J Clin Oncol 31 3623-3630 [2013]
  • Preoperative chemotherapy in primary operable breast cancer : results from the European Organization for Research and Treatment of Cancer trial 10902
    van der Hage JA J Clin Oncol 19 : 4224 ~ 4237 [2001]
  • Preoperative chemotherapy in primary operable breast cancer : results from the European Organization for Research and Treatment of Cancer trial 10902
    van der Hage JA J Clin Oncol 19 4224-4237 [2001]
  • Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    Rastogi P J Clin Oncol 26 : 778 ~ 785 [2008]
  • Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    Rastogi P J Clin Oncol 26 778-785 [2008]
  • Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
    Jones SE J Clin Oncol 24 : 5381 ~ 5387 [2006]
  • Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
    Jones SE J Clin Oncol 24 5381-5387 [2006]
  • Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    Welt A Ann Oncol 16 : 64 ~ 69 [2005]
  • Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    Welt A Ann Oncol 16 64-69 [2005]
  • Optimal two-stage designs for phase II clinical trials
    Simon R Control Clin Trials 10 : 1 ~ 10 [1989]
  • Optimal two-stage designs for phase II clinical trials
    Simon R Control Clin Trials 10 1-10 [1989]
  • Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
    Ring AE Br J Cancer 91 : 2012 ~ 2017 [2004]
  • Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
    Ring AE Br J Cancer 91 2012-2017 [2004]
  • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    Therasse P J Natl Cancer Inst 92 205-216 [2000]
  • New guidelines to evaluate the response to treatment in solid tumors : European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    Therasse P J Natl Cancer Inst 92 : 205 ~ 216 [2000]
  • Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer : phase III randomized GeparTrio trial
    von Minckwitz G J Natl Cancer Inst 100 : 542 ~ 551 [2008]
  • Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer : phase III randomized GeparTrio trial
    von Minckwitz G J Natl Cancer Inst 100 542-551 [2008]
  • Neoadjuvant capecitabine and docetaxel(plus trastuzumab) : an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer
    Wildiers H Ann Oncol 22 : 588 ~ 594 [2011]
  • Neoadjuvant capecitabine and docetaxel(plus trastuzumab) : an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer
    Wildiers H Ann Oncol 22 588-594 [2011]
  • Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
    Schwartz GF Cancer 73 : 362 ~ 369 [1994]
  • Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
    Schwartz GF Cancer 73 362-369 [1994]
  • Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
    유창훈 Journal of Breast Cancer 15 (2) : 203 ~ 210 [2012]
  • Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
    유창훈 Journal of Breast Cancer 15 2 203-210 [2012]
  • HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
    Andre F Breast Cancer Res Treat 108 : 183 ~ 190 [2008]
  • HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
    Andre F Breast Cancer Res Treat 108 183-190 [2008]
  • Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm : results of a randomized trial in a single centre
    Mauriac L Ann Oncol 2 : 347 ~ 354 [1991]
  • Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm : results of a randomized trial in a single centre
    Mauriac L Ann Oncol 2 347-354 [1991]
  • Decline in the use of anthracyclines for breast cancer
    Giordano SH J Clin Oncol 30 : 2232 ~ 2239 [2012]
  • Decline in the use of anthracyclines for breast cancer
    Giordano SH J Clin Oncol 30 2232-2239 [2012]
  • Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
    Kuerer HM J Clin Oncol 17 : 460 ~ 469 [1999]
  • Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
    Kuerer HM J Clin Oncol 17 460-469 [1999]
  • Capecitabine and vinorelbine in metastatic breast cancer
    Chan A Eur J Cancer 45 : 2253 ~ 2265 [2009]
  • Capecitabine and vinorelbine in metastatic breast cancer
    Chan A Eur J Cancer 45 2253-2265 [2009]
  • Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
    Ahn Jin Hee Journal of Korean Medical Science 19 (4) : 547 ~ 553 [2004]
  • Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
    Ahn Jin Hee Journal of Korean Medical Science 19 4 547-553 [2004]
  • Can we abandon anthracyclines for early breast cancer patients?
    Henderson IC Oncology (Williston Park) 25 : 115 ~ 127 [2011]
  • Can we abandon anthracyclines for early breast cancer patients?
    Henderson IC Oncology (Williston Park) 25 115-127 [2011]
  • Antitumor activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human tumor xenograft models
    Sawada N Proc Am Assoc Cancer Res 43 : 1088 ~ [2002]
  • Antitumor activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human tumor xenograft models
    Sawada N Proc Am Assoc Cancer Res 43 1088- [2002]
  • Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline-and taxane-pretreated metastatic breast cancer : findings from the EORTC 10001 randomized phase II trial
    Pajk B Breast 17 : 180 ~ 185 [2008]
  • Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline-and taxane-pretreated metastatic breast cancer : findings from the EORTC 10001 randomized phase II trial
    Pajk B Breast 17 180-185 [2008]
  • Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer : 10-year follow-up of the phase 3 randomised BCIRG 001 trial
    Mackey JR Lancet Oncol 14 : 72 ~ 80 [2013]
  • Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer : 10-year follow-up of the phase 3 randomised BCIRG 001 trial
    Mackey JR Lancet Oncol 14 72-80 [2013]
  • Adjuvant docetaxel for node-positive breast cancer
    Martin M N Engl J Med 352 : 2302 ~ 2313 [2005]
  • Adjuvant docetaxel for node-positive breast cancer
    Martin M N Engl J Med 352 2302-2313 [2005]
  • A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee KS Breast Cancer Res Treat 109 : 481 ~ 489 [2008]
  • A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee KS Breast Cancer Res Treat 109 481-489 [2008]